InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,447.87
(
-0.31%
)
US TECH 100
18,978.00
(
-1.19%
)
Dow Jones
39,411.21
(
0.67%
)
Brent Oil
85.14
(
-0.16%
)
Bitcoin
60,442.46
(
0.30%
)
Post# of 52895
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Singhania

Send PM Follow Ignore
Followers 0
Posts 361
Boards Moderated 0
Alias Born 07/16/2014

Singhania

Re: None

Tuesday, 06/04/2024 11:46:31 AM

Tuesday, June 04, 2024 11:46:31 AM

Post# of 52895
$OCX - Can the favorable data about VitaGraft Kidney in the New England Journal of Medicine be the catalyst for the Oncocyte Corporation (NASDAQ:OCX) stock today?

The product could open up a massive new market for the company as currently there are no FDA approved drugs for AMR management in the market.

Just need patience and we might double our money once people start noticing this undervalued stock.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up